Literature DB >> 33352898

Unusual Case of Pancreatic Adenocarcinoma with Bladder Metastasis.

Giorgia Arcovito1, Iosè Di Stefano1, Laura Boldrini1, Francesca Manassero2, Jacopo Durante2, Alessio Tognarelli2, Pinuccia Faviana1.   

Abstract

Background: The pancreas can be the site of neoplasms of several histogenetic origins; in most cases, tumors derive from the exocrine component, and ductal adenocarcinoma certainly prevails over the others. This tumor displays remarkably aggressive behavior, and it is often diagnosed at a late stage of disease. Case presentation: We discuss the rare case of a 76-year-old male with locally advanced pancreatic head adenocarcinoma who developed uncommon metastatic disease. The bladder constitutes a very rare site of metastases, mostly deriving from melanoma, gastric, lung and breast cancers. The bladder's secondary involvement in pancreatic malignancies represents an extremely unusual occurrence, and there are very few cases described in the literature to date. Conclusions: The finding of pancreatic adenocarcinoma metastases leads to a poor prognosis, and patients who are diagnosed at this stage constitute 53% of cases, with a 5-year survival of 3%. Although rare, therefore, the diagnostic hypothesis of pancreatic ductal adenocarcinoma (DAC) metastases to the bladder must, in some cases, be considered, especially if accompanied by a clinical picture that may suggest it.

Entities:  

Keywords:  bladder metastasis; immunohistochemistry; metastatic pancreatic

Mesh:

Year:  2020        PMID: 33352898      PMCID: PMC7766336          DOI: 10.3390/medicina56120708

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  21 in total

1.  Second-line oxaliplatin, folinic acid, and fluorouracil versus folinic acid and fluorouracil alone for gemcitabine-refractory pancreatic cancer: outcomes from the CONKO-003 trial.

Authors:  Helmut Oettle; Hanno Riess; Jens M Stieler; Gerhard Heil; Ingo Schwaner; Jörg Seraphin; Martin Görner; Matthias Mölle; Tim F Greten; Volker Lakner; Sven Bischoff; Marianne Sinn; Bernd Dörken; Uwe Pelzer
Journal:  J Clin Oncol       Date:  2014-06-30       Impact factor: 44.544

Review 2.  Pancreatic Ductal Adenocarcinoma and Its Variants.

Authors:  Claudio Luchini; Paola Capelli; Aldo Scarpa
Journal:  Surg Pathol Clin       Date:  2016-10-12

Review 3.  Imaging mimics of pancreatic ductal adenocarcinoma.

Authors:  Namita S Gandhi; Myra K Feldman; Ott Le; Gareth Morris-Stiff
Journal:  Abdom Radiol (NY)       Date:  2018-02

Review 4.  Immunohistochemistry of colorectal carcinoma: current practice and evolving applications.

Authors:  Ross James Taliano; Mark LeGolvan; Murray B Resnick
Journal:  Hum Pathol       Date:  2012-08-29       Impact factor: 3.466

5.  Diagnosis and management of pancreatic cancer.

Authors:  Maria Syl D De La Cruz; Alisa P Young; Mack T Ruffin
Journal:  Am Fam Physician       Date:  2014-04-15       Impact factor: 3.292

6.  Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.

Authors:  Julia Mayerle; Holger Kalthoff; Regina Reszka; Beate Kamlage; Erik Peter; Bodo Schniewind; Sandra González Maldonado; Christian Pilarsky; Claus-Dieter Heidecke; Philipp Schatz; Marius Distler; Jonas A Scheiber; Ujjwal M Mahajan; F Ulrich Weiss; Robert Grützmann; Markus M Lerch
Journal:  Gut       Date:  2017-01-20       Impact factor: 23.059

7.  Global targetome analysis reveals critical role of miR-29a in pancreatic stellate cell mediated regulation of PDAC tumor microenvironment.

Authors:  Shatovisha Dey; Sheng Liu; Tricia D Factora; Solaema Taleb; Primavera Riverahernandez; Lata Udari; Xiaoling Zhong; Jun Wan; Janaiah Kota
Journal:  BMC Cancer       Date:  2020-07-13       Impact factor: 4.430

8.  Surgical and local treatment of hepatic metastasis in pancreatic ductal adenocarcinoma: recent advances and future prospects.

Authors:  Tianqiang Jin; Chaoliu Dai; Feng Xu
Journal:  Ther Adv Med Oncol       Date:  2020-06-23       Impact factor: 8.168

Review 9.  Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches.

Authors:  Michael Orth; Philipp Metzger; Sabine Gerum; Julia Mayerle; Günter Schneider; Claus Belka; Maximilian Schnurr; Kirsten Lauber
Journal:  Radiat Oncol       Date:  2019-08-08       Impact factor: 3.481

10.  Rare Metastasis of Primary Pancreatic Adenocarcinoma to the Bladder.

Authors:  Anup Shah; Praneet Korrapati; Jerome Siegel; Franklin Kasmin
Journal:  ACG Case Rep J       Date:  2018-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.